文献速递心脏核医学肿瘤 PET/CT

未用激素心脏结节病患者心肌FDG摄取定位对预后风险分层的作用

Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis.
PubMed 文献 · J Nucl Cardiol · 2021-07-06

本研究纳入90例临床疑似心脏结节病且未用皮质激素的患者,用FDG-PET评估炎症,其中42例确认有活动性心脏受累。中位随访4.9年,15例发生不良事件(6例持续性室速、9例死亡);调整左室收缩功能不全后,右室或左室基底前侧壁FDG摄取合并心肌灌注异常可预测不良事件。

要点

  • 未用激素的心脏结节病患者中,右室或左室基底前侧壁FDG摄取合并灌注异常提示长期不良事件风险。
  • 研究确认活动性心脏受累42例,中位随访4.9年,15例发生不良事件。
  • 调整左室收缩功能不全后,上述FDG摄取定位仍可预测不良事件。

核心结论

  • 在未用皮质激素的心脏结节病患者中,右室或左室基底前侧壁FDG摄取合并心肌灌注异常有助于长期预后风险分层。

研究设计与样本

  • 连续纳入90例临床疑似心脏结节病、为评估炎症行FDG-PET成像的患者。
  • 不良事件定义为持续性室速、心脏移植和全因死亡的复合终点,通过病历、除颤器 interrogation 和电话访谈确认。
  • 中位随访4.9年,采用Cox比例风险模型调整左室收缩功能不全后分析预测因素。

主要发现

  • 90例中42例(平均年龄62.9±12.0岁,76.2%女性)确认有活动性心脏受累。
  • 中位随访4.9年,15例心脏结节病患者发生不良事件,包括6例持续性室速和9例死亡。
  • 调整左室收缩功能不全后,右室或左室基底前侧壁FDG摄取合并心肌灌注异常可预测不良事件。

临床怎么用

  • 对未用皮质激素的心脏结节病患者,可关注FDG-PET上右室或左室基底前侧壁FDG摄取合并灌注异常,用于长期风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The localization of myocardial 18F-fluorodeoxyglucose (FDG) uptake affecting long-term clinical outcomes has not been elucidated in patients with corticosteroid-naïve cardiac sarcoidosis (CS). OBJECTIVES: This study sought to investigate the localization of myocardial FDG uptake on positron emission tomography (PET) and myocardial perfusion abnormality to predict adverse events (AEs) for a long-term follow-up in patients with corticosteroid-naïve CS. METHODS: Consecutive 90 patients with clinical suspicion of CS who underwent FDG-PET imaging to assess for inflammation were enrolled. AEs were defined as a composite of sustained ventricular tachycardia (VT), heart transplantation, and all-cause death, which were ascertained by medical records, defibrillator interrogation, and telephone interviews. RESULTS: Of 90 patients, 42 patients (mean age 62.9 ± 12.0 years; 76.2% females) were confirmed active cardiac involvement. Over a median follow-up of 4.9 years, 15 patients with CS experienced AEs including 6 sustained ventricular tachycardias (VT) and 9 deaths. Cox proportional-hazards model after adjustment for left ventricular systolic dysfunction revealed that FDG uptake in the right ventricle (RV) or basal anterolateral area of the left ventricle (LV) with myocardial perfusion abnormality was predictive of AEs. CONCLUSIONS: FDG uptake in the RV or basal anterolateral area of the LV with myocardial perfusion abnormality provides long-term prognostic risk stratification in patients with corticosteroid-naïve CS.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Bekki M, Tahara N, Tahara A, et al. Localization of myocardial FDG uptake for prognostic risk stratification in corticosteroid-naïve cardiac sarcoidosis. J Nucl Cardiol. 2021. PMID: 34228338. doi:10.1007/s12350-021-02684-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。